Liminatus Pharma LIMN
NASDAQ LIMN
$3.77 +0.04 (+1.06%)
As of: Oct 1, 2026 · 11:45 AM EDT

Liminatus Pharma (LIMN) Current Assets (2024 - 2026)

Updated

Liminatus Pharma's Current Assets was $3.39 million in Q2 2026, up 90.3% from $1.78 million a year earlier and up 22.1% from the prior quarter.

Analysis

Liminatus Pharma (LIMN) Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Current Assets at Liminatus Pharma came in at $500,574, down 90.5% from FY2024.

  • In earlier years, Current Assets was $5.28 million in FY2024.
  • The Q2 2026 figure marks the highest quarterly Current Assets since Q4 2024.
  • Per Business Quant data, LIMN's Current Assets in the three quarters before Q2 2026 was $2.78 million (Q1 2026), $500,574 (Q4 2025) and $1.2 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 59.77 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.67 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 27.97 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 13.95 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 12.54 Bn
10 Liminatus Pharma 4.18 Mn 4.18 Mn - 3.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.39 Mn
Mar 31, 2026 2.78 Mn
Dec 31, 2025 500,574.00
Sep 30, 2025 1.20 Mn
Jun 30, 2025 1.78 Mn
Dec 31, 2024 5.28 Mn
API Access

Liminatus Pharma Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=LIMN&period=max&api_key=YOUR_API_KEY